(6R,8R,9R,10R,13R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-[1-[(2R)-2-(dimethylamino)-3-hydroxypropyl]piperidin-4-yl]-13-hydroxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecan-11-one
C36H70N4O8 — CID 167098021
Data last refreshed: (MolForge compound catalog, from PubChem)
About (6R,8R,9R,10R,13R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-[1-[(2R)-2-(dimethylamino)-3-hydroxypropyl]piperidin-4-yl]-13-hydroxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecan-11-one
(6R,8R,9R,10R,13R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-[1-[(2R)-2-(dimethylamino)-3-hydroxypropyl]piperidin-4-yl]-13-hydroxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecan-11-one (PubChem CID 167098021) has the molecular formula C36H70N4O8 and a molecular weight of 686.98 g/mol. Its IUPAC name is (6R,8R,9R,10R,13R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-[1-[(2R)-2-(dimethylamino)-3-hydroxypropyl]piperidin-4-yl]-13-hydroxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecan-11-one.
Molecular Properties
| Compound Name | (6R,8R,9R,10R,13R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-[1-[(2R)-2-(dimethylamino)-3-hydroxypropyl]piperidin-4-yl]-13-hydroxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecan-11-one |
|---|---|
| PubChem CID | 167098021 |
| Molecular Formula | C36H70N4O8 |
| Molecular Weight | 686.98 g/mol |
| Exact Mass | 686.52 |
| IUPAC Name | (6R,8R,9R,10R,13R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-[1-[(2R)-2-(dimethylamino)-3-hydroxypropyl]piperidin-4-yl]-13-hydroxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecan-11-one |
| SMILES | CO[C@]1(C)C[C@@H](C)CN(C)C(C2CCN(C[C@H](CO)N(C)C)CC2)CO[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O |
| InChI | InChI=1S/C36H70N4O8/c1-23-18-36(6,45-12)32(48-33-30(42)28(38(9)10)17-24(2)47-33)25(3)31(43)35(4,5)34(44)46-22-29(39(11)19-23)26-13-15-40(16-14-26)20-27(21-41)37(7)8/h23-30,32-34,41-42,44H,13-22H2,1-12H3/t23-,24-,25+,27-,28+,29?,30-,32-,33+,34-,36-/m1/s1 |
| InChIKey | CDARBUPIJQUUOM-TZZDNXRKSA-N |
| XLogP | 1.74 |
| TPSA | 127.64 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 686.98 |
| LogP ≤ 5 | 1.74 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167098021 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.